Pictet & Cie Europe Sa Has Raised Pfizer (PFE) Holding; Oak Ridge Investments Cut Its Rsp Permian (RSPP) Holding

August 12, 2018 - By Lisa Delgado

Pfizer Inc. (NYSE:PFE) Logo

Pictet & Cie Europe Sa increased Pfizer Inc (PFE) stake by 37.65% reported in 2018Q1 SEC filing. Pictet & Cie Europe Sa acquired 12,722 shares as Pfizer Inc (PFE)’s stock declined 3.80%. The Pictet & Cie Europe Sa holds 46,512 shares with $1.65M value, up from 33,790 last quarter. Pfizer Inc now has $239.42B valuation. The stock decreased 0.17% or $0.07 during the last trading session, reaching $40.93. About 17.26 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 10.95% since August 12, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 23/03/2018 – Pfizer Closes Below 200-Day Moving Average: Technicals; 23/05/2018 – PFIZER INC – DECISION IS SUPPORTED BY TOPLINE RESULTS FROM TAFAMIDIS PHASE 3 TRANSTHYRETIN CARDIOMYOPATHY (ATTR-ACT) STUDY; 19/03/2018 – BIODURO PACT WITH PFIZER LEADS TO CREATION OF A SHELF-STABLE; 15/05/2018 – FDA approves first epoetin alfa biosimilar for the treatment of anemia; 09/04/2018 – Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio; 21/03/2018 – Reckitt Benckiser pulls out of Pfizer consumer health auction; 01/05/2018 – PFE STILL PLANNING DECISION THIS YEAR ON CONSUMER HEALTH UNIT; 04/04/2018 – U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small; 16/05/2018 – Phase lll lMpower150 Study Showed Genentech’s TECENTRIQ and Avastin Plus Carboplatin and Paclitaxel Helped People With a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin Plus Carboplatin and Paclitaxel; 06/03/2018 – FDA POSTS STAFF REPORT ON PFIZER’S XELJANZ AHEAD OF PANEL

Oak Ridge Investments Llc decreased Rsp Permian Inc (RSPP) stake by 29.67% reported in 2018Q1 SEC filing. Oak Ridge Investments Llc sold 82,322 shares as Rsp Permian Inc (RSPP)’s stock rose 20.33%. The Oak Ridge Investments Llc holds 195,097 shares with $9.15 million value, down from 277,419 last quarter. Rsp Permian Inc now has $7.63 billion valuation. The stock increased 0.99% or $0.47 during the last trading session, reaching $47.83. About 3.44M shares traded or 93.85% up from the average. RSP Permian, Inc. (NYSE:RSPP) has risen 17.35% since August 12, 2017 and is uptrending. It has outperformed by 4.78% the S&P500. Some Historical RSPP News: 28/03/2018 – CONCHO RESOURCES INC – SEES DEAL TO BE IMMEDIATELY ACCRETIVE TO KEY PER-SHARE METRICS; 28/03/2018 – CONCHO RESOURCES INC – AS PART OF DEAL, CO EXPECTS TO REALIZE OVER $60 MLN IN ANNUAL CORPORATE LEVEL SAVINGS; 28/03/2018 – CONCHO RESOURCES SAYS UPON DEAL TERMINATION WITH RSP PERMIAN UNDER SPECIFIED CIRCUMSTANCES, CO TO PAY RSP A FEE OF $350 MLN – SEC FILING; 28/03/2018 – Concho buys RSP Permian in $9.5bn shale deal; 02/05/2018 – RSP Permian 1Q Rev $276.3M; 28/03/2018 – RSP Permian, Inc (RSPP) ALERT: Johnson Fistel, LLP Launches an Investigation into the Proposed Sale of RSP Permian, Inc. and En; 28/03/2018 – RSP sells on Concho approach, source says [00:45 BST29 Mar 2018] [Proprietary] []; 07/03/2018 Moody’s Upgrades Rsp Permian To Ba3; Stable Outlook; 28/03/2018 – Concho Buys RSP, Cheniere Seeks $6.4 for Terminal: Energy Wrap; 28/03/2018 – Oil producer Concho to buy rival RSP in Permian push

Among 7 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Pfizer had 9 analyst reports since February 26, 2018 according to SRatingsIntel. The rating was maintained by Credit Suisse with “Neutral” on Wednesday, August 1. Jefferies maintained the shares of PFE in report on Friday, April 13 with “Hold” rating. Jefferies maintained Pfizer Inc. (NYSE:PFE) on Monday, February 26 with “Hold” rating. Cantor Fitzgerald initiated Pfizer Inc. (NYSE:PFE) rating on Thursday, June 7. Cantor Fitzgerald has “Buy” rating and $4500 target. The company was downgraded on Thursday, April 5 by Barclays Capital. The firm has “Outperform” rating given on Wednesday, May 2 by BMO Capital Markets. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, August 1. BMO Capital Markets has “Outperform” rating and $44 target. The firm has “Buy” rating by Bank of America given on Wednesday, August 1.

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It worsened, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Mason Street Advsrs Ltd Liability Corp, a Wisconsin-based fund reported 829,220 shares. Sectoral Asset has invested 3.13% in Pfizer Inc. (NYSE:PFE). Bokf Na has invested 0.59% of its portfolio in Pfizer Inc. (NYSE:PFE). 13,256 are held by Ghp Inv Inc. Massachusetts-based Oakmont Ptnrs Llc has invested 0.16% in Pfizer Inc. (NYSE:PFE). 39.66 million were accumulated by Fisher Asset Mngmt Llc. Cutler Cap Mngmt Lc invested in 0.55% or 38,000 shares. The Connecticut-based Asset Mgmt Grp Inc has invested 0.47% in Pfizer Inc. (NYSE:PFE). Advsr Management Limited Liability Co holds 0.05% of its portfolio in Pfizer Inc. (NYSE:PFE) for 18,210 shares. Copeland Capital Ltd Co owns 7,939 shares. Hartford Investment Mngmt has 0.85% invested in Pfizer Inc. (NYSE:PFE) for 1.21 million shares. New York-based Trustco Bancshares Corporation N Y has invested 1.36% in Pfizer Inc. (NYSE:PFE). Ifrah reported 28,288 shares. Chickasaw Capital Ltd Liability holds 0.01% or 6,675 shares in its portfolio. Virginia-based Chase Investment Counsel has invested 0.11% in Pfizer Inc. (NYSE:PFE).

Since February 24, 2018, it had 0 buys, and 14 selling transactions for $19.59 million activity. $190,117 worth of Pfizer Inc. (NYSE:PFE) shares were sold by CORNWELL W DON. JOHNSON RADY A sold $998,666 worth of Pfizer Inc. (NYSE:PFE) on Tuesday, March 13. LUND-JURGENSEN KIRSTEN had sold 9,510 shares worth $353,677. HILL CHARLES H had sold 42,393 shares worth $1.52M. Dolsten Mikael sold $501,398 worth of stock. OLSON LAURIE J also sold $692,582 worth of Pfizer Inc. (NYSE:PFE) on Wednesday, June 6. The insider READ IAN C sold $4.76 million.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: which released: “Pfizer: The Outlook Cannot Justify Current Valuation” on August 07, 2018, also with their article: “Pfizer: Keep On Reinvesting Dividends” published on July 24, 2018, published: “Why Pfizer Stock Gained 10% in July” on August 06, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: and their article: “Better Buy: Johnson & Johnson vs. Pfizer” published on August 02, 2018 as well as‘s news article titled: “Pfizer (PFE) Q2 2018 Results – Earnings Call Transcript” with publication date: July 31, 2018.

Pictet & Cie Europe Sa decreased Alphabet Inc stake by 1,290 shares to 36,047 valued at $37.39M in 2018Q1. It also reduced Alphabet Inc stake by 3,727 shares and now owns 17,633 shares. Johnson & Johnson (NYSE:JNJ) was reduced too.

Since March 29, 2018, it had 0 insider buys, and 2 sales for $5.99 million activity. $3.06M worth of RSP Permian, Inc. (NYSE:RSPP) was sold by Wallace Family Partnership – LP.

Among 17 analysts covering RSP Permian (NYSE:RSPP), 7 have Buy rating, 0 Sell and 10 Hold. Therefore 41% are positive. RSP Permian had 28 analyst reports since February 28, 2018 according to SRatingsIntel. The company was downgraded on Monday, April 16 by Roth Capital. The firm has “Hold” rating given on Thursday, March 29 by RBC Capital Markets. The rating was maintained by Stephens on Tuesday, March 13 with “Buy”. Williams Capital Group maintained the stock with “Buy” rating in Wednesday, February 28 report. Seaport Global downgraded the stock to “Hold” rating in Tuesday, April 3 report. Stifel Nicolaus downgraded RSP Permian, Inc. (NYSE:RSPP) rating on Monday, April 9. Stifel Nicolaus has “Hold” rating and $4900 target. BMO Capital Markets maintained the stock with “Buy” rating in Monday, March 12 report. On Thursday, March 29 the stock rating was downgraded by Jefferies to “Hold”. The stock of RSP Permian, Inc. (NYSE:RSPP) has “In-Line” rating given on Thursday, March 29 by Imperial Capital. Guggenheim maintained the shares of RSPP in report on Friday, March 16 with “Buy” rating.

More news for RSP Permian, Inc. (NYSE:RSPP) were recently published by:, which released: “Concho Resources completes acquisition of RSP Permian, Inc.” on July 20, 2018.‘s article titled: “Stifel Projects 150% Upside For Lilis Energy In Bullish Initiation” and published on August 01, 2018 is yet another important article.

Investors sentiment increased to 1.21 in 2018 Q1. Its up 0.04, from 1.17 in 2017Q4. It is positive, as 40 investors sold RSPP shares while 82 reduced holdings. 80 funds opened positions while 68 raised stakes. 130.18 million shares or 3.12% less from 134.36 million shares in 2017Q4 were reported. Fifth Third State Bank holds 0% or 125 shares in its portfolio. Ftb holds 313 shares. Luminus Mgmt Ltd Llc invested in 0.05% or 47,024 shares. Cap Rech Global Investors holds 510,000 shares or 0.01% of its portfolio. Scout Invs stated it has 366,632 shares. Prelude Capital Management Limited Com reported 114,884 shares. Gardner Lewis Asset Lp has 300,000 shares. Legal General Grp Incorporated Public Ltd invested 0% of its portfolio in RSP Permian, Inc. (NYSE:RSPP). State Street has invested 0.01% in RSP Permian, Inc. (NYSE:RSPP). Confluence Investment Management Ltd Liability Corporation reported 6,202 shares. Arosa Lp invested in 105,000 shares or 0.68% of the stock. Amalgamated Bank & Trust stated it has 0.03% of its portfolio in RSP Permian, Inc. (NYSE:RSPP). Hanson Mcclain stated it has 23 shares or 0% of all its holdings. Oak Ridge Invests Ltd Llc has 0.51% invested in RSP Permian, Inc. (NYSE:RSPP) for 195,097 shares. Moreover, Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Management has 0.01% invested in RSP Permian, Inc. (NYSE:RSPP) for 30,000 shares.

RSP Permian, Inc. (NYSE:RSPP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts